Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
Academic Article
Publication Date:
2020
abstract:
Hospitalized acutely ill medical patients are at risk for fatal and major thromboembolic events. Whether use of extended-duration primary thromboprophylaxis can prevent such events is unknown.
Iris type:
Articolo su Rivista
Keywords:
hospitalized; major bleeding; medically ill; rivaroxaban; thromboembolic events
List of contributors:
Spyropoulos, Alex C; Ageno, Walter; Albers, Gregory W; Elliott, C Gregory; Halperin, Jonathan L; Hiatt, William R; Maynard, Gregory A; Steg, P Gabriel; Weitz, Jeffrey I; Lu, Wentao; Spiro, Theodore E; Barnathan, Elliot S; Raskob, Gary E
Published in: